Carpal Tunnel — Factors Affecting Risk Recall in Open Carpal Tunnel Release Surgery
Citation(s)
Hong P, Makdessian AS, Ellis DA, Taylor SM Informed consent in rhinoplasty: prospective randomized study of risk recall in patients who are given written disclosure of risks versus traditional oral discussion groups. J Otolaryngol Head Neck Surg. 2009 Jun;38(3):369-74.
Kessler TM, Nachbur BH, Kessler W Patients' perception of preoperative information by interactive computer program-exemplified by cholecystectomy. Patient Educ Couns. 2005 Nov;59(2):135-40.
Nadeau DP, Rich JN, Brietzke SE Informed consent in pediatric surgery: Do parents understand the risks? Arch Otolaryngol Head Neck Surg. 2010 Mar;136(3):265-9. doi: 10.1001/archoto.2010.5.
Ono S, Clapham PJ, Chung KC Optimal management of carpal tunnel syndrome. Int J Gen Med. 2010 Aug 30;3:255-61.
Schenker Y, Fernandez A, Sudore R, Schillinger D Interventions to improve patient comprehension in informed consent for medical and surgical procedures: a systematic review. Med Decis Making. 2011 Jan-Feb;31(1):151-73. doi: 10.1177/0272989X10364247. Epub 2010 Mar 31. Review.
Siau D, List RJ, Hussin N, Woolford TJ Do printed information leaflets improve recall of the procedure and risks in adult tonsillectomy? How we do it. Clin Otolaryngol. 2010 Dec;35(6):503-6. doi: 10.1111/j.1749-4486.2010.02227.x.
Weiss MG, Ramakrishna J, Somma D Health-related stigma: rethinking concepts and interventions. Psychol Health Med. 2006 Aug;11(3):277-87.
Factors Affecting Risk Recall in Open Carpal Tunnel Release Surgery
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.